3738358
Last Update Posted: 2019-01-30
Recruiting has ended
All Genders accepted | 19 Years-79 Years |
39 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
This clinical study will be conducted to evaluate the efficacy and safety of trehalose in patients with fatty liver disease. After 12-week intake, subjects will be checked up fat content in liver using CT scan.
Eligibility
Relevant conditions:
Non-alcoholic Fatty Liver
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov